Irish Health Repository >
Hospital Research >
Adelaide Meath Hospital Tallaght >
Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.
|Files in This Item:|
There are no files associated with this item.
|Title: ||Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.|
|Affiliation: ||Division of Medical Sciences, Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham, Birmingham, UK.|
|Citation: ||Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly. 2009, 71 (1):74-81 Clin. Endocrinol. (Oxf)|
|Publisher: ||Clinical endocrinology|
|Journal: ||Clinical endocrinology|
|Issue Date: ||Jul-2009 |
|PubMed ID: ||19178529|
|Abstract: ||The aims of treatment in patients with acromegaly are to achieve serum GH/IGF-I concentrations associated with cure or normalization of mortality and alleviation of symptoms.|
Human Growth Hormone
Insulin-Like Growth Factor I
|Appears in Collections: ||Adelaide Meath Hospital Tallaght|
this identifier to cite or link
to this item:
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.